AI assistant
Dolby Laboratories, Inc. — Director's Dealing 2023
Jul 14, 2023
30828_dirs_2023-07-14_74c3191f-5e2c-4a42-a7f9-3063047eb2f9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2023-07-12
Reporting Person: SHERMAN MARK ANDREW (EVP, Gen. Counsel & Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-07-12 | Class A Common Stock | M | 21000 | $62.32 | Acquired | 77730 | Direct |
| 2023-07-12 | Class A Common Stock | S | 21000 | $89.00 | Disposed | 56730 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-07-12 | Employee Stock Option (right to buy) | $62.32 | M | 21000 | Disposed | 2024-12-15 | Class A Common Stock (21000) | Direct |
Footnotes
F1: Shares held following the reported transactions include 39,803 restricted stock units, which are subject to forfeiture until they vest
F2: Shares include 356 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2023.
F3: This performance-based stock option award was granted for a total of 28,000 shares of Class A Common Stock at target. The number of shares actually earned and vested upon the achievement of total shareholder return performance criteria measured during a three-year performance period ended on December 15, 2020 was at 96% of target, or 26,880 shares.